APA (7th ed.) Citation

Kojima, H., Yamashita, A., Nakano, Y., Booka, A., Tatara, Y., Yamada, T., . . . Suzuma, K. (2026). Significant Correlation Between Choroidal Thickness and Decrease in Choroidal Blood Flow After Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration. Ophthalmology & Therapy, 15(1), 393. https://doi.org/10.1007/s40123-025-01279-9

Chicago Style (17th ed.) Citation

Kojima, Hirokazu, et al. "Significant Correlation Between Choroidal Thickness and Decrease in Choroidal Blood Flow After Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration." Ophthalmology & Therapy 15, no. 1 (2026): 393. https://doi.org/10.1007/s40123-025-01279-9.

MLA (9th ed.) Citation

Kojima, Hirokazu, et al. "Significant Correlation Between Choroidal Thickness and Decrease in Choroidal Blood Flow After Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration." Ophthalmology & Therapy, vol. 15, no. 1, 2026, p. 393, https://doi.org/10.1007/s40123-025-01279-9.